title: Dose-response relationship and pharmacogenetics of anti-RhD monoclonal antibodies.
authors.forename: David
authors.initials: D
authors.lastname: Ternant
authors.forename: Marc
authors.initials: M
authors.lastname: Ohresser
authors.forename: Cécile
authors.initials: C
authors.lastname: Thomas
authors.forename: Guillaume
authors.initials: G
authors.lastname: Cartron
authors.forename: Hervé
authors.initials: H
authors.lastname: Watier
authors.forename: Gilles
authors.initials: G
authors.lastname: Paintaud
mesh_terms: D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015703:Antigens, CD / Q000235:genetics; D004305:Dose-Response Relationship, Drug; D004905:Erythrocyte Aging; D006801:Humans; D010597:Pharmacogenetics; D011110:Polymorphism, Genetic; D017452:Receptors, IgG / Q000235:genetics; D012204:Rh-Hr Blood-Group System / Q000276:immunology*
chemical_list: D000911:Antibodies, Monoclonal; D015703:Antigens, CD; C496124:FCGR3A protein, human; C080568:Fc gamma receptor IIA; D017452:Receptors, IgG; D012204:Rh-Hr Blood-Group System; C026410:Rho(D) antigen